The health
authorities in Burkina Faso have given the go-ahead for a new malaria vaccine
to be used on young children offering hope that millions of lives can be saved.
The R21 vaccine has already been
approved in Ghana and Nigeria.
Malaria is the leading cause of infant mortality in Burkina Faso, and
Health Minister Robert Kargougou says this new vaccine will be an extremely
important tool in the effort to eliminate the disease. Researchers say trials
involving 5,000 children have been successful.
The R21 vaccine will be available for children aged between five months
and 36 months - and each dose is likely to cost a couple of US dollars. The
Serum Institute of India can produce two million doses a year, and a factory is
also to be built in Ghana which has already approved use of the vaccine along
with Nigeria.
Tags
Government has been asked to handle all cases Spina Bifida and Hydrocephalus conditions in Chlidren
lack of clean water and electricity hampering health service delivery in Butandiga town council
Ministry of Health Urges public to take safety proactive measures in current weather conditions.
Cure Children's hospital seeks over 600 Millions to treat spina bifida and hydrocephalus in children
Nauyo Bugema town council have decried the high rate of weed consumption by young people in the area
The shortage of blood at Mbale Regional Referral Hospital has led to the death of ten patients.
The World Health Organization (WHO) says Malawi is going through its worst ever outbreak of cholera.
HIV/AIDS experts are calling for increased vigilance for students staying in hostels in urban areas
Popular and Recent News
Comment